6/27/25

Science to startup: real talk on biotech founding | Hilary Schulz & William Heath, Persephoni Bio

From science to startup: real talk on biotech founding paths! Early-stage biotech founders often find themselves navigating uncharted territory—something Hilary Schultz and Dr. William Heath of Persephoni BioPartners know all too well as they guide others on the path from science to startup. In this episode of the Nucleate Podcast, Hillary Schultz and Dr. William Heath share how their unique journeys from clinical medicine and pharmaceutical R&D to early-stage investing led them to co-found Persephoni Bio, a venture studio focused on transforming breakthrough science into scalable biotech companies. Hillary and William reveal the most overlooked reasons biotech startups struggle, highlighting that success often hinges more on the team than the technology. They offer candid insights into IP strategy, founder dynamics, and patient-centered development, while also emphasizing the importance of resilience, adaptability, and a growth mindset.

Previous

Building the Wyss Institute, Organs-on-Chips & Fighting for Science — Don Ingber | Frameshifts Ep. 9